Daily Newsletter

30 October 2023

Daily Newsletter

30 October 2023

Aidoc collaborates with UZ Brussel for PE treatment with AI

Aidoc's AI helps to assess chest CT exams for PE and prioritise potential positive cases within the radiology workflow.

RanjithKumar Dharma October 27 2023

Aidoc has collaborated with Belgium-based University Hospital Brussels (UZ Brussel) for the expedited treatment of pulmonary embolism (PE) with artificial intelligence (AI).

The company will work with UZ Brussel’s Pulmonary Embolism Response Team (PERT) to deploy AI for cross-departmental care coordination to expedite treatment for suspected PE patients.

Aidoc automatically identifies suspected positive PE cases and sends an automatic alert to PERT, facilitating quick decision-making and the delivery of treatment.

Aidoc's always-on AI system is already in use at UZ Brussel, evaluating chest CT exams for PE and giving priority to potential positive cases within the radiology workflow.

When Aidoc's AI detects a suspected acute PE case, the PERT team, which includes an interventional radiologist, pulmonologist, cardiologist, and intensivist, are alerted through Aidoc's mobile app.

The notification contains images and clinical data, including the right ventricle-to-left ventricle ratio, which is a crucial adverse outcomes predictor in acute PE.

The chat feature of the mobile app enables secure discussions across departments and facilitates quick decision-making.

Aidoc's advanced operating system, the Aidoc aiOS, automates every stage of the imaging process, from acquisition and algorithm activation, to care escalation.

Aidoc Europe Sales and Innovation RVP Jeremy De Sy said: “As our first partner in Europe, UZ Brussel is no stranger to AI; they were the first to implement our entire suite of radiology AI solutions and now they are the very first hospital in Europe to deploy AI across service lines to manage and treat acute PE patients.

“This innovative approach not only enhances patient care, but also sets the stage for a promising future of AI-driven healthcare across Europe.”

Is the healthcare industry ready to fully embrace the benefits of digitalization and AI?

The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close